Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Persistent fossil fuel over-dependence puts health of current and future generations in jeopardy
25 October 2022
Autistic people are more likely to experience depression and anxiety during pregnancy
26 October 2022

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Updated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in patients with localized muscle-invasive bladder cancer, reveal no significant safety concerns with the combination.

Comments are closed.